Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
58
MET Quote, Financials, Valuation and Earnings
Last price:
$81.32
Seasonality move
:
0.34%
Day range:
$79.48 - $82.32
52-week range:
$64.61 - $89.05
Dividend yield:
2.65%
P/E ratio:
16.40x
P/S ratio:
0.83x
P/B ratio:
1.82x
Volume:
7.9M
Avg. volume:
3.6M
1-year change:
24.75%
Market cap:
$56.3B
Revenue:
$66.4B
EPS (TTM):
$4.96
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $68.7B | $66.8B | $63.7B | $67.8B | $66.4B | |
| Revenue Growth (YoY) | 1.18% | -2.84% | -4.67% | 6.55% | -2.09% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.6B | $5.8B | $5.8B | $5.9B | $6.2B | |
| Other Inc / (Exp) | $553M | $495M | $545M | $520M | $297M | |
| Operating Expenses | $7.2B | $6.6B | $6.4B | $6.5B | $6.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $955M | $913M | $920M | $938M | $1B | |
| EBT. Incl. Unusual Items | $6.8B | $6.9B | $8.5B | $6.4B | $2.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $886M | $1.5B | $1.6B | $1.1B | $560M | |
| Net Income to Company | $5.9B | $5.4B | $6.9B | $5.3B | $1.6B | |
| Minority Interest in Earnings | -$10M | -$11M | -$21M | -$18M | -$24M | |
| Net Income to Common Excl Extra Items | $5.9B | $5.4B | $6.9B | $5.3B | $1.6B | |
| Basic EPS (Cont. Ops) | $6.10 | $5.72 | $7.71 | $6.35 | $1.82 | |
| Diluted EPS (Cont. Ops) | $6.06 | $5.68 | $7.65 | $6.30 | $1.81 | |
| Weighted Average Basic Share | $937.6M | $907.8M | $862.7M | $803.2M | $757.7M | |
| Weighted Average Diluted Share | $944.4M | $913.2M | $869.4M | $808.9M | $762.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $7.8B | $7.8B | $9.4B | $7.3B | $3.2B | |
| Revenue (Reported) | $68.7B | $66.8B | $63.7B | $67.8B | $66.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $7.8B | $7.8B | $9.4B | $7.3B | $3.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $15.5B | $15.2B | $22.5B | $15.7B | $18.3B | |
| Revenue Growth (YoY) | -15.94% | -1.48% | 47.64% | -30.36% | 16.6% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.4B | $1.4B | $1.5B | $1.5B | |
| Other Inc / (Exp) | $455M | $147M | $217M | $52M | $94M | |
| Operating Expenses | $1.6B | $1.5B | $1.6B | $1.7B | $1.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $229M | $240M | $239M | $265M | $257M | |
| EBT. Incl. Unusual Items | $923M | $2B | $1.4B | $534M | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $214M | $453M | $248M | $39M | $653M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$3M | -$5M | -$5M | -$6M | $1M | |
| Net Income to Common Excl Extra Items | $706M | $1.6B | $1.2B | $489M | $1.3B | |
| Basic EPS (Cont. Ops) | $0.70 | $1.78 | $1.38 | $0.56 | $1.82 | |
| Diluted EPS (Cont. Ops) | $0.69 | $1.77 | $1.37 | $0.56 | $1.81 | |
| Weighted Average Basic Share | $908.7M | $854.9M | $795.8M | $751.4M | $699.3M | |
| Weighted Average Diluted Share | $913.7M | $861.2M | $800.7M | $755.5M | $703.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.2B | $2.3B | $1.7B | $799M | $2.3B | |
| Revenue (Reported) | $15.5B | $15.2B | $22.5B | $15.7B | $18.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.2B | $2.3B | $1.7B | $799M | $2.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $65B | $66.6B | $68.8B | $63.1B | $70.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.9B | -- | $5.9B | $6.1B | $6.1B | |
| Other Inc / (Exp) | $1.5B | $72M | $549M | $307M | $364M | |
| Operating Expenses | $6.7B | $7.8B | $6.5B | $6.7B | $6.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $907M | $698M | $914M | $1B | $1B | |
| EBT. Incl. Unusual Items | $6.7B | $7B | $6B | $3.2B | $5.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $878M | $1.5B | $803M | $678M | $1.4B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$6M | -$15M | -$21M | -$20M | -$21M | |
| Net Income to Common Excl Extra Items | $5.8B | $5.5B | $5.2B | $2.5B | $3.8B | |
| Basic EPS (Cont. Ops) | $6.13 | $6.16 | $5.78 | $2.75 | $4.98 | |
| Diluted EPS (Cont. Ops) | $6.09 | $6.15 | $5.73 | $2.72 | $4.96 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $7.6B | $7.7B | $7B | $4.3B | $6.2B | |
| Revenue (Reported) | $65B | $66.6B | $68.8B | $63.1B | $70.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $7.6B | $7.7B | $7B | $4.3B | $6.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $48.1B | $48B | $52B | $47.5B | $51.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $2.8B | $4.3B | $4.5B | $4.5B | |
| Other Inc / (Exp) | $1.4B | $927M | $417M | $204M | $271M | |
| Operating Expenses | $4.8B | $6B | $4.8B | $5B | $5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $683M | $468M | $690M | $776M | $778M | |
| EBT. Incl. Unusual Items | $6.8B | $6.8B | $4.3B | $1.2B | $4.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $1.5B | $617M | $233M | $1.1B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$11M | -$15M | -$15M | -$17M | -$14M | |
| Net Income to Common Excl Extra Items | $5.2B | $5.3B | $3.7B | $971M | $3.2B | |
| Basic EPS (Cont. Ops) | $5.55 | $6.02 | $4.38 | $1.06 | $4.21 | |
| Diluted EPS (Cont. Ops) | $5.51 | $6.01 | $4.34 | $1.06 | $4.19 | |
| Weighted Average Basic Share | $2.7B | $2.6B | $2.4B | $2.3B | $2.1B | |
| Weighted Average Diluted Share | $2.7B | $2.6B | $2.4B | $2.3B | $2.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $7.4B | $7.3B | $5B | $2B | $5B | |
| Revenue (Reported) | $48.1B | $48B | $52B | $47.5B | $51.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $7.4B | $7.3B | $5B | $2B | $5B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $16.6B | $19.8B | $20B | $20.2B | $20.6B | |
| Short Term Investments | $331.7B | $358.7B | $347.5B | $281.7B | $287.5B | |
| Accounts Receivable, Net | $20.4B | $17.9B | $17.1B | $17.4B | $29B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $368.7B | $396.4B | $384.8B | $319.3B | $337.3B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $353.8B | $382.6B | $375.5B | $307.5B | $313.3B | |
| Goodwill | $9.3B | $10.1B | $9.5B | $9.3B | $9.2B | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $740.5B | $795.1B | $759.7B | $663.1B | $687.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $136M | $293M | $241M | $76M | $119M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $1.1B | $2.5B | $562M | $505M | |
| Long-Term Debt | $16.6B | $17.8B | $17.1B | $17.7B | $18.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $674.1B | $720.3B | $692B | $632.9B | $657.3B | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | |
| Other Common Equity Adj | $13.1B | $18.1B | $10.9B | -$22.6B | -$19.2B | |
| Common Equity | $66.1B | $74.6B | $67.5B | $29.9B | $30B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $238M | $259M | $267M | $244M | $238M | |
| Total Equity | $66.4B | $74.8B | $67.7B | $30.1B | $30.3B | |
| Total Liabilities and Equity | $740.5B | $795.1B | $759.7B | $663.1B | $687.6B | |
| Cash and Short Terms | $348.3B | $378.5B | $367.5B | $301.9B | $308.1B | |
| Total Debt | $16.9B | $18.1B | $17.4B | $17.9B | $18.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.4B | $19B | $22.2B | $14.9B | $21.8B | |
| Short Term Investments | $357.6B | $348.2B | $276B | $277.5B | $298.4B | |
| Accounts Receivable, Net | $20.7B | $17.8B | $17.7B | $19B | $31.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $402.8B | $385B | $316.1B | $311.4B | $351.9B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $379.6B | $374.7B | $300.3B | $302.8B | $322.6B | |
| Goodwill | $9.4B | $9.6B | $9B | $9.1B | $9.2B | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $780.5B | $761.7B | $650.1B | $652.1B | $705B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $351M | $346M | $183M | $161M | $404M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $974M | $612M | $601M | $785M | |
| Long-Term Debt | $17.7B | $17.2B | $17.7B | $18.6B | $18.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $706.9B | $692.3B | $624.8B | $626.2B | $673.8B | |
| Common Stock | $12M | $12M | $12M | $12M | $12M | |
| Other Common Equity Adj | $16B | $12.1B | -$28.7B | -$24.3B | -$17.2B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $989M | -- | -- | -- | -- | |
| Minority Interest, Total | $253M | $283M | $254M | $237M | $279M | |
| Total Equity | $73.6B | $69.3B | $25.3B | $25.9B | $31.2B | |
| Total Liabilities and Equity | $780.5B | $761.7B | $650.1B | $652.1B | $705B | |
| Cash and Short Terms | $382B | $367.1B | $298.2B | $292.4B | $320.2B | |
| Total Debt | $18B | $17.5B | $17.9B | $18.8B | $18.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.9B | $5.4B | $6.9B | $5.3B | $1.6B | |
| Depreciation & Amoritzation | $630M | $619M | $694M | $673M | $718M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$514M | $842M | $362M | $299M | -$2B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.8B | $11.6B | $12.3B | $13B | $13.7B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$1.1B | -$3.1B | $820M | -$709M | -$755M | |
| Cash From Investing | -$17.6B | -$18.6B | -$11.2B | -$2.6B | -$10.2B | |
| Dividends Paid (Ex Special Dividend) | -$1.8B | -$1.9B | -$1.8B | -$1.8B | -$1.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1.1B | $29M | $1B | $2.7B | |
| Long-Term Debt Repaid | -$906M | -$99M | -$582M | -$85M | -$1.9B | |
| Repurchase of Common Stock | -$2.3B | -$2.2B | -$4.8B | -$3.3B | -$3.1B | |
| Other Financing Activities | $6.2B | $8.2B | $4.2B | $5B | $4.4B | |
| Cash From Financing | $4.6B | $10.7B | -$1.1B | -$9.9B | -$2.9B | |
| Beginning Cash (CF) | $15.8B | $16.6B | $20.6B | $20.1B | $20.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $768M | $3.8B | $34M | $476M | $535M | |
| Ending Cash (CF) | $16.6B | $19.8B | $20.1B | $20.2B | $20.6B | |
| Levered Free Cash Flow | $13.8B | $11.6B | $12.3B | $13B | $13.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.8B | $3.5B | $4.3B | $3.5B | $4.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$260M | -$565M | -$380M | -$217M | -$140M | |
| Cash From Investing | -$6.7B | -$8.3B | -$4.1B | -$3B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$478M | -$476M | -$464M | -$459M | -$450M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $50M | $14M | $1B | $1.1B | $332M | |
| Long-Term Debt Repaid | -$82M | -$512M | -$54M | -$70M | -$160M | |
| Repurchase of Common Stock | -$80M | -$1B | -$674M | -$792M | -$774M | |
| Other Financing Activities | $1.9B | $108M | $721M | $362M | $685M | |
| Cash From Financing | $2.9B | -$1.1B | $1.7B | -$848M | -$1.1B | |
| Beginning Cash (CF) | $24.3B | $25.1B | $20.5B | $15.4B | $20.8B | |
| Foreign Exchange Rate Adjustment | $117M | -$200M | -$289M | -$160M | $118M | |
| Additions / Reductions | -$1M | -$5.9B | $1.9B | -$345M | $861M | |
| Ending Cash (CF) | $24.4B | $19.1B | $22.2B | $14.9B | $21.8B | |
| Levered Free Cash Flow | $3.8B | $3.5B | $4.3B | $3.5B | $4.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.7B | $12.4B | $15.8B | $10.8B | $15.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$1.4B | -$343M | -$1.2B | -$986M | -$257M | |
| Cash From Investing | -$23.5B | -$10.5B | -$5.3B | -$11B | -$5.6B | |
| Dividends Paid (Ex Special Dividend) | -$1.9B | -$1.9B | -$1.8B | -$1.8B | -$1.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | -- | $1B | $2.3B | $2B | |
| Long-Term Debt Repaid | -$100M | -$544M | -$119M | -$1.8B | -$2.4B | |
| Repurchase of Common Stock | -$830M | -$5.2B | -$3.9B | -$2.8B | -$3.7B | |
| Other Financing Activities | $10.1B | $3.7B | $4.2B | $3.8B | $3.8B | |
| Cash From Financing | $16.7B | -$7B | -$6.6B | -$7.2B | -$2.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.9B | -$5.1B | $4B | -$7.4B | $6.8B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $11.7B | $12.4B | $15.8B | $10.8B | $15.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $6.5B | $7.3B | $10.7B | $8.5B | $10B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$974M | $1.7B | -$309M | -$586M | -$88M | |
| Cash From Investing | -$16.4B | -$8.3B | -$2.4B | -$10.8B | -$6.1B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.4B | -$1.4B | -$1.3B | -$1.3B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $29M | $1B | $2.3B | $1.7B | |
| Long-Term Debt Repaid | -$95M | -$540M | -$77M | -$1.8B | -$2.3B | |
| Repurchase of Common Stock | -$580M | -$3.6B | -$2.7B | -$2.2B | -$2.8B | |
| Other Financing Activities | $8.7B | $4.2B | $4.3B | $3.2B | $2.5B | |
| Cash From Financing | $17.7B | -$40M | -$5.5B | -$2.8B | -$2.6B | |
| Beginning Cash (CF) | $65B | $65.9B | $64.2B | $54.1B | $61.3B | |
| Foreign Exchange Rate Adjustment | $6M | -$392M | -$756M | -$236M | -$120M | |
| Additions / Reductions | $7.8B | -$1.1B | $2.8B | -$5B | $1.2B | |
| Ending Cash (CF) | $72.8B | $64.4B | $66.3B | $48.8B | $62.4B | |
| Levered Free Cash Flow | $6.5B | $7.3B | $10.7B | $8.5B | $10B | |
Get MET Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MET
Sector
P/E ratio
16.40x
12.02x
PEG ratio
0.20x
0.36x
P/B ratio
1.82x
1.05x
Price / LTM sales
0.83x
2.55x
Growth Metrics
MET
Sector
Revenue growth
16.6%
6.08%
Earnings growth
223.21%
6.45%
Revenue (5-year growth)
-0.45%
5.85%
Earnings forecast
$2.18
$0.56
Profitability
MET
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
7.91%
5.27%
Return on assets
0.55%
0.98%
Return on equity
13.1%
9.43%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
29
Balance Sheet
MET
Sector
Total cash
$320.2B
$617M
Short term investments
$287.5B
$408.4M
Total assets
$687.6B
$4.5B
Long term debt
$18.8B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 6.11% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 16.63% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 1.74% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
